Does Armour Thyroid Cause Headaches?
Armour Thyroid (desiccated thyroid) does not directly cause headaches as a primary adverse effect, but thyroid hormone therapy can trigger headaches in specific clinical contexts, particularly when dosing causes thyrotoxicosis or when initiating therapy in patients with underlying cardiovascular disease.
Understanding the Relationship Between Thyroid Hormones and Headaches
The relationship between thyroid dysfunction and headaches is bidirectional and complex:
Thyroid Dysfunction Can Cause Headaches
- Hypothyroidism is associated with headaches in approximately 30% of patients, presenting as slight, nonpulsatile, continuous, bilateral headaches that respond to salicylates and resolve with thyroid hormone therapy 1
- Thyrotoxicosis (excess thyroid hormone) can present acutely with severe headache as a striking feature, though other clinical signs of hyperthyroidism are typically present 2
- There is a documented positive correlation between migraine and hypothyroidism, particularly Hashimoto's disease 3, 4
Armour Thyroid-Specific Considerations
Armour Thyroid contains both T4 (levothyroxine) and T3 (liothyronine) in a 4:1 ratio by weight, providing 38 mcg T4 and 9 mcg T3 per grain 5, 6. This combination differs from synthetic levothyroxine monotherapy and can produce distinct physiological effects.
When Headaches May Occur with Armour Thyroid
1. Overtreatment/Thyrotoxicosis
If Armour Thyroid dosing causes thyrotoxicosis (suppressed TSH with elevated thyroid hormones), headaches can develop as part of the hyperthyroid symptom complex 2. The T3 component in desiccated thyroid is absorbed more rapidly and can cause more pronounced fluctuations in thyroid hormone levels compared to T4 monotherapy.
2. Cardiovascular Stress
The FDA label explicitly warns that thyroid hormones should be used with great caution in patients with suspected cardiovascular disease, including the elderly 6. In these populations, initiating therapy—even at appropriate doses—can aggravate underlying cardiac conditions, potentially manifesting as headaches among other symptoms.
3. Rapid Dose Escalation
Starting with excessive doses rather than the recommended low doses (15-30 mg in elderly or cardiac patients) 6 can precipitate symptoms including headaches.
Clinical Monitoring Approach
Monitor for signs of thyrotoxicity that may accompany headaches:
- Chest pain or palpitations
- Increased pulse rate (studies show DTE may increase heart rate) 7, 8
- Excessive sweating and heat intolerance
- Nervousness or anxiety
- Weight loss (DTE causes modest weight loss of 3-4 lbs) 9, 8
Laboratory assessment should include:
- TSH levels (may be lower with DTE than levothyroxine) 8
- Free T4 (significantly lower with DTE) 8
- Total T3 (significantly higher with DTE, mean difference +50.90 ng/dL) 8
Important Caveats
Headaches as a Symptom of Undertreated Hypothyroidism
If a patient develops or continues to have headaches while on Armour Thyroid, consider that the headaches may represent inadequately treated hypothyroidism rather than a side effect of the medication 1. Approximately 30% of hypothyroid patients experience headaches that resolve with adequate thyroid hormone replacement.
Pre-existing Migraine
Patients with pre-existing migraine may experience changes in headache patterns during thyroid hormone therapy, as there is genetic overlap between migraine susceptibility and thyroid dysfunction (shared genes include THADA and ITPK1) 4.
Quality of Evidence Limitation
The overall quality of evidence for DTE is moderate to very low, with most studies hampered by inferior design and lacking long-term safety data 7. The two available RCTs found no significant difference in symptom scores between DTE and levothyroxine 7, 9.
Practical Management Algorithm
If headaches develop after starting Armour Thyroid:
- Check TSH, free T4, and total T3 within 2-4 weeks
- Assess for other signs of thyrotoxicosis (tachycardia, weight loss, tremor)
- If TSH <0.1 mIU/L or patient has cardiovascular symptoms, reduce dose immediately 6
If headaches persist despite normal thyroid function:
- Consider that headaches may be unrelated to thyroid therapy
- Evaluate for other headache etiologies
- Consider trial of levothyroxine monotherapy if DTE-specific effects (higher T3 peaks) are suspected
For patients with pre-existing cardiovascular disease:
- Initiate at 15-30 mg daily 6
- Monitor heart rate and cardiovascular symptoms closely
- Accept that achieving euthyroid state may need to be balanced against cardiovascular tolerance
The key principle: Headaches are not a typical direct adverse effect of appropriately dosed Armour Thyroid, but rather may signal either overtreatment (thyrotoxicosis) or undertreatment (persistent hypothyroidism), both of which are correctable with dose adjustment guided by clinical assessment and thyroid function testing.